StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Medpace's EV/EBITDA was 30.9× on Nov 11, 2026, against 32.4× a year earlier. Over the last 5 years it ranged from 18.3× to 37.4×, with a median of 26.0×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202630.9×+0.3
2025Dec 31, 202530.6×+7.0
2024Dec 31, 202423.7×−4.9
2023Dec 29, 202328.6×+2.4
2022Dec 30, 202226.1×−11.2
2021Dec 31, 202137.4×+5.2
2020Dec 31, 202032.1×+7.9
2019Dec 31, 201924.2×+1.2
2018Dec 31, 201823.0×−1.3
2017Dec 29, 201724.3×−17.1
2016Dec 30, 201641.5×–

More Medpace figures

See a number that looks wrong?